Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1992 2
1993 1
1995 1
1997 1
1998 1
2000 1
2001 1
2002 2
2005 1
2008 1
2011 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA, Counsell C, Tseng MC. Sandercock PA, et al. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000119. doi: 10.1002/14651858.CD000119.pub3. Cochrane Database Syst Rev. 2008. PMID: 18646059 Updated. Review.
For previous versions of this review we searched MedStrategy (1995) and also contacted pharmaceutical companies. SELECTION CRITERIA: Randomised trials comparing heparinoids or low-molecular-weight heparins with standard unfractionated heparin in people with …
For previous versions of this review we searched MedStrategy (1995) and also contacted pharmaceutical companies. SELECTION CRITERIA: Randomi …
Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T, Perry CM. Ibbotson T, et al. Drugs. 2002;62(15):2283-314. doi: 10.2165/00003495-200262150-00016. Drugs. 2002. PMID: 12381232 Review.
Danaparoid (danaparoid sodium) is a low molecular weight heparinoid which has undergone clinical study for use as continued anticoagulant therapy in patients with heparin-induced thrombocytopenia (HIT), for the prophylaxis and treatment of deep …
Danaparoid (danaparoid sodium) is a low molecular weight heparinoid which has undergone clinical study fo …
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock P, Counsell C, Stobbs SL. Sandercock P, et al. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000119. doi: 10.1002/14651858.CD000119.pub2. Cochrane Database Syst Rev. 2005. PMID: 15846600 Updated. Review.
OBJECTIVES: The objective of this review was to compare the effects of low-molecular-weight heparins or heparinoids with those of unfractionated heparin in people with acute, confirmed or presumed, ischaemic stroke (sudden blockage of an artery …
OBJECTIVES: The objective of this review was to compare the effects of low-molecular-weight heparins or heparinoids wit …
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Counsell C, Sandercock P. Counsell C, et al. Cochrane Database Syst Rev. 2001;(4):CD000119. doi: 10.1002/14651858.CD000119. Cochrane Database Syst Rev. 2001. PMID: 11687069 Updated. Review.
OBJECTIVES: The objective of this review was to compare the effects of low molecular weight heparins or heparinoids with those of unfractionated heparin in people with acute confirmed or presumed ischaemic stroke. ...Date of most recent search: …
OBJECTIVES: The objective of this review was to compare the effects of low molecular weight heparins or heparinoids wit …
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Counsell C, Sandercock P. Counsell C, et al. Cochrane Database Syst Rev. 2000;(2):CD000119. doi: 10.1002/14651858.CD000119. Cochrane Database Syst Rev. 2000. PMID: 10796301 Updated. Review.
OBJECTIVES: The objective of this review was to compare the effects of low molecular weight heparins or heparinoids with those of unfractionated heparin in people with acute confirmed or presumed ischaemic stroke. ...Date of most recent search: …
OBJECTIVES: The objective of this review was to compare the effects of low molecular weight heparins or heparinoids wit …
Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke.
Field TS, Hill MD. Field TS, et al. Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):5-19. doi: 10.1177/1076029611412362. Epub 2011 Jul 6. Clin Appl Thromb Hemost. 2012. PMID: 21733942 Free article. Review.
Additional means of thromboprophylaxis in stroke include mechanical methods (ie, compression stockings) to prevent venous stasis and medical therapy including antiplatelets, heparins, and heparinoids. Risk of VTE must be balanced by potential risk of hemorrhagic com …
Additional means of thromboprophylaxis in stroke include mechanical methods (ie, compression stockings) to prevent venous stasis and …
Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
[No authors listed] [No authors listed] JAMA. 1998 Apr 22-29;279(16):1265-72. JAMA. 1998. PMID: 9565006 Clinical Trial.
Low molecular weight heparins and heparinoids have been shown to be effective in preventing deep vein thrombosis in persons with stroke, and they might be effective in reducing unfavorable outcomes following ischemic stroke. OBJECTIVE: To test w …
Low molecular weight heparins and heparinoids have been shown to be effective in preventing deep vein thrombosis in per …
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Turpie AG. Turpie AG. Haemostasis. 1992;22(2):92-8. doi: 10.1159/000216300. Haemostasis. 1992. PMID: 1379969 Review.
Venous thrombo-embolism is a common complication in patients with acute ischaemic stroke. Without prophylaxis, deep vein thrombosis occurs in 60-75% of patients with dense hemiplegia, usually in the paralyzed limb, and 1-2% suffer fatal pulmonary embolism. Orgaran ( …
Venous thrombo-embolism is a common complication in patients with acute ischaemic stroke. Without prophylaxis, deep vein throm …
Prophylaxis of venous thromboembolism in stroke patients.
Turpie AG. Turpie AG. Semin Thromb Hemost. 1997;23(2):155-7. doi: 10.1055/s-2007-996084. Semin Thromb Hemost. 1997. PMID: 9200340
Venous thromboembolism is a common complication in patients with acute thrombotic stroke. Estimates of the frequency of deep vein thrombosis (DVT) in untreated patients range from 20 to 75%. ...A number of methods of preventing DVT have been shown to be safe and eff …
Venous thromboembolism is a common complication in patients with acute thrombotic stroke. Estimates of the frequency of deep v …
15 results